| In millions, except per share items | Mar-31-13 | Mar-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
| Revenues | -1.9 | -39.8 | -54.8 | 0.0 | 0.0 |
| Revenue growth | -95.2% | | -185846.8% | 404.7% | |
| Cost of goods sold | -123.2 | -40.4 | 5.6 | 0.0 | 0.0 |
| Gross profit | 121.3 | 0.6 | -60.4 | 0.0 | 0.0 |
| Gross margin | -6386.4% | -1.5% | 110.2% | 1.9% | 4.8% |
| Selling, general and administrative [+] | 48.5 | 17.2 | 12.7 | 0.2 | 0.0 |
| Sales and marketing | | | | 0.2 | 0.0 |
| General and administrative | 48.5 | 17.2 | 12.7 | 0.0 | 0.0 |
| Other selling, general and administrative | | | | 0.2 | 0.0 |
| Other operating expenses | 147.7 | 6.6 | -54.8 | 0.4 | 0.1 |
| EBITDA [+] | -74.7 | -23.2 | -18.3 | | |
| EBITDA growth | 221.8% | | 2976.8% | 518.4% | |
| EBITDA margin | 3930.3% | 58.3% | 33.4% | -2013.9% | -1643.6% |
| Depreciation and amortization | 0.1 | 0.0 | 0.0 | | |
| EBIT [+] | -74.8 | -23.2 | -18.3 | -0.6 | -0.1 |
| EBIT growth | 222.2% | | 2977.2% | 518.4% | |
| EBIT margin | 3936.0% | 58.3% | 33.4% | -2013.9% | -1643.6% |
| Interest expense | 7.2 | 1.9 | 2.0 | | |
| Interest expense | 7.2 | 1.9 | 2.0 | | |
| Other income (expense), net [+] | 2.2 | -38.4 | -56.8 | 0.4 | 0.0 |
| Gain (loss) on debt retirement | | -2.0 | -2.0 | | |
| Pre-tax income | -79.9 | -63.6 | -77.1 | -0.2 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Minority interest | 4.1 | 3.4 | 3.1 | | |
| Net income | -88.0 | -70.3 | -80.2 | -0.2 | 0.0 |
| Net margin | 4631.4% | 176.7% | 146.4% | -666.8% | -819.4% |
| |
| Basic EPS [+] | ($76.19) | ($125.62) | ($3.64) | | ($0.01) |
| Growth | -39.4% | | | | |
| Diluted EPS [+] | ($76.19) | ($125.62) | ($3.64) | | ($0.01) |
| Growth | -39.4% | | | | |
| |
| Shares outstanding (basic) [+] | 1.2 | 0.6 | 22.0 | | 4.8 |
| Growth | 106.3% | | | | |
| Shares outstanding (diluted) [+] | 1.2 | 0.6 | 22.0 | | 4.8 |
| Growth | 106.3% | | | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |